Cardiochirurgia European Hospital
Rome, 00152, Italy
NCT Number: NCT00950547
PURPOSE: Autotransfusion devices may be employed in cardiac surgery to decrease allogenic blood requirements. Limitations of previous trials include the use of cell saver systems in selected high risk patients only or the lack of blood transfusion-sparing strategies. The aim of this prospective randomized study is to evaluate the efficacy of cell salvage CardioPAT routinely used in cardiac surgery.
METHODS: The investigators will randomize 350 patients in two groups: group 1 receives a CardioPAT cell saver device (175 patients), group 2 doesn't receive any cell saver device. The incidence of allogenic blood transfusion and clinical outcome in both groups are evaluated.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Rome, 00152, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cell Saver System at bedside for ICU stay
Chest drains as usual with no possibility to reinfuse lost blood
Time frame: 10 days after surgery
Time frame: 30 days after surgery
Cardiochirurgia E.H.
Other
Routinely Use of CardioPAT Cell Saver in Cardiac Surgery: A Prospective Randomized Study Focused on Allogenic Blood Transfusion and Clinical Outcome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00458783
Blood Transfusion, Cardiac Surgery
Cleveland, Ohio, United States
View Trial DetailsNCT00879463
Blood Transfusion, Cardiac Surgery
Larissa, Thessaly, Greece
View Trial DetailsNCT07671469
Anemia, Blood Transfusion
Palo Alto, California, United States
View Trial DetailsNCT06142825
Blood Transfusion
Minneapolis, Minnesota, United States
View Trial Details